Find clinical trials for Lymphoma in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Atlanta, GA, USA:
DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) may be able to join ...
Phase 1
Atlanta, Georgia, United States and 20 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Atlanta, Georgia, United States and 66 other locations
This phase II trial studies the effect of acalabrutinib and obinutuzumab in treating patients with follicular lymphoma or other indolent non...
Phase 2
Atlanta, Georgia, United States
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Atlanta, Georgia, United States and 36 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Atlanta, Georgia, United States and 59 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Atlanta, Georgia, United States and 59 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Atlanta, Georgia, United States and 71 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Lawrenceville, Georgia, United States and 215 other locations
to see how well they work in treating patients with classic Hodgkin lymphoma that has come back or does not respond to treatment. Drugs used...
Phase 1, Phase 2
Atlanta, Georgia, United States and 1 other location
dose escalation and expansion clinical trial to evaluate the safety, tolerability and PK of HMPL-689 in patients with relapsed or refractory lymphomas...
Phase 1
Atlanta, Georgia, United States and 26 other locations
Clinical trials
Research sites
Resources
Legal